RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Mass General Brigham Ventures
M

Mass General Brigham Ventures portfolio

Mass General Brigham Ventures has 6 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Type: Corporate venture.
Portfolio on Recent Funding: 6.
Deals, last 12 months: 2.
Rounds led: 1 of 11.
Capital in their rounds: $992M.
Latest deal: Oyster Therapeutics · Nov 10, 2026.
About this page

It is a corporate venture investor based in Boston, US, founded in 2020. It led 1 of the 11 rounds it joined. Its most recent investment on record is Oyster Therapeutics's $60M Series A round in November 2026, alongside Global Brain Corporation, 4BIO Capital, Eli Lilly and 5 others. By category, its portfolio leans toward Health and bio (6) and Manufacturing and industrial (1). It has co-invested with Pontifax, Samsara Biocapital and RA Capital Management, most often Pontifax (5 rounds).

About Mass General Brigham Ventures

Firm type: Corporate venture.
Headquarters: Boston, US.
Founded: 2020.
Stages: Seed, Series A.
Sectors: AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.

What Mass General Brigham Ventures invests in

Mass General Brigham Ventures recent investments

How Mass General Brigham Ventures invests

StageDealsCapital in rounds
Series B+ 6 55%$711M
Series A 5 45%$281M
YearDealsCapital in rounds
2021 3 27%$139M
2023 3 27%$400M
2024 1 9%$57M
2025 2 18%$218M
2026 2 18%$178M

Mass General Brigham Ventures portfolio companies

CompanyRound with Mass General Brigham VenturesTotal raisedLatest raise
OOyster Therapeutics
Health and bio
Series A · $60M$60MNov 10, 2026
Series A
CClaris Bio
Health and bio
Series B+ · $118M$175MJul 28, 2026
Series B+
CCarta Healthcare
Health and bio
Series B+ · $18M$80MJun 7, 2025
Series B+
AAbcuro
Health and bio
Series B+ · $200M$463MAug 18, 2026
Series B+
MMediar Therapeutics
Health and bio
Series A · $105M$181MJan 7, 2026
Series B+
AAmolyt Pharma
Health and bio
Series B+ · $140M$294MJan 6, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 11 rounds on Recent Funding that name Mass General Brigham Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Mass General Brigham Ventures, which is a subset of its real portfolio. API: /api/v1/investors/mass-general-brigham-ventures (get a free API key). More: the most active VC firms and new venture capital funds.